Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects

Record identifier

TN_cdi_proquest_journals_2554373219

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2554373219

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects

Full title

First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational science, 2021, Vol.14 (4), p.1314-1326

Record Identifier

TN_cdi_proquest_journals_2554373219

Language

English

Formats

Publication information

Publisher

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2554373219

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2554373219

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card